Cargando…

Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives

Diabetic kidney disease (DKD) is one of the major chronic complications of diabetes mellitus (DM), as well as a main cause of end-stage renal disease. Over the last few years, substantial research studies have revealed a contributory role of gut microbiota in the process of DM and DKD. Metabolites o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Jia-Ran, Wang, Zi-Ting, Sun, Jiao-Jiao, Yang, Ying-Ying, Li, Xue-Xin, Wang, Xin-Ru, Shi, Yue, Zhu, Yuan-Yuan, Wang, Rui-Ting, Wang, Mi-Na, Xie, Fei-Yu, Wei, Peng, Liao, Ze-Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052008/ https://www.ncbi.nlm.nih.gov/pubmed/35582668 http://dx.doi.org/10.4239/wjd.v13.i4.308

Ejemplares similares

Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis
por: Luo, Ming, et al.
Publicado: (2023)

Gut microbiota in obesity
por: Liu, Bing-Nan, et al.
Publicado: (2021)

Diabetes and gut microbiota
por: Xi, Yue, et al.
Publicado: (2021)

Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus
por: Kant, Ravi, et al.
Publicado: (2022)

Gut microbiota and inflammatory bowel disease: The current status and perspectives
por: Zheng, Lie, et al.
Publicado: (2021)

The interplay between innate lymphoid cells and microbiota
por: Wang, Rui, et al.
Publicado: (2023)

The gut microbiota and its interactions with cardiovascular disease
por: Xu, Hui, et al.
Publicado: (2020)

Oxidative stress bridges the gut microbiota and the occurrence of frailty syndrome
por: Chen, Si-Yue, et al.
Publicado: (2022)

Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity
por: Wei, Yan-Xia, et al.
Publicado: (2021)

Influence of gut microbiota on neuropsychiatric disorders
por: Cenit, María Carmen, et al.
Publicado: (2017)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Update on gut microbiota in gastrointestinal diseases
por: Nishida, Atsushi, et al.
Publicado: (2022)

Microbiota regulation in constipation and colorectal cancer
por: Wang, Li-Wei, et al.
Publicado: (2023)

Impact of Helicobacter pylori infection on gut microbiota
por: Iino, Chikara, et al.
Publicado: (2021)

Updated review on immune factors in pathogenesis of Crohn’s disease
por: Li, Na, et al.
Publicado: (2018)

Effects of a high fat diet on intestinal microbiota and gastrointestinal diseases
por: Zhang, Mei, et al.
Publicado: (2016)

Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines
por: Wang, Xian-Ze, et al.
Publicado: (2020)

Gut microbiota and COVID-19: An intriguing pediatric perspective
por: Valentino, Maria Sole, et al.
Publicado: (2022)

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

Liver injury in COVID-19: Detection, pathogenesis, and treatment
por: Cai, Yue, et al.
Publicado: (2021)

Potential role of the gut microbiota in synthetic torpor and therapeutic hypothermia
por: Sisa, Claudia, et al.
Publicado: (2017)

Role of gut microbiota on intestinal barrier function in acute pancreatitis
por: Li, Xue-Yang, et al.
Publicado: (2020)

Gut microbiota mediated molecular events and therapy in liver diseases
por: Qi, Xiaoqiang, et al.
Publicado: (2020)

Interaction between gut microbiota and COVID-19 and its vaccines
por: Leung, John S M
Publicado: (2022)

Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes
por: Huang, Qi-You, et al.
Publicado: (2020)

Advances in medical treatment for pancreatic neuroendocrine neoplasms
por: Li, Yuan-Liang, et al.
Publicado: (2022)

From Network Analysis to Functional Metabolic Modeling of the Human Gut Microbiota
por: Bauer, Eugen, et al.
Publicado: (2018)

Gut microbiota in common elderly diseases affecting activities of daily living
por: Shimizu, Yukihiro
Publicado: (2018)

Does the Gut Microbiota Modulate Host Physiology through Polymicrobial Biofilms?
por: Yang, Jiayue, et al.
Publicado: (2020)

The Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy
por: Kim, Jaeho, et al.
Publicado: (2021)

Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2023)

Advanced glycation end productions and tendon stem/progenitor cells in pathogenesis of diabetic tendinopathy
por: Shi, Liu, et al.
Publicado: (2021)

Complex Glycan Catabolism by the Human Gut Microbiota: The Bacteroidetes Sus-like Paradigm
por: Martens, Eric C., et al.
Publicado: (2009)

Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
por: Zhang, Chun-Ye, et al.
Publicado: (2022)

Management of procedural pain in the intensive care unit
por: Guo, Na-Na, et al.
Publicado: (2022)

Pathogenesis of autoimmune hepatitis
por: Fan, Jun-Hua, et al.
Publicado: (2021)

Pancreatic β cell regeneration induced by clinical and preclinical agents
por: Wang, Kang-Li, et al.
Publicado: (2021)

Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation
por: Xiao, Shuiming, et al.
Publicado: (2014)

Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
por: Nishida, Atsushi, et al.
Publicado: (2021)

Role of immune escape in different digestive tumours
por: Du, Xin-Zhu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9d5mjh3q0kdbk6r4737if5up09